loadpatents
Patent applications and USPTO patent grants for ROUTLEDGE; Carol.The latest application filed is for "combination of sabcomeline with a neuroleptic agent to treat psychotic disorders".
Patent | Date |
---|---|
Combination Of Sabcomeline With A Neuroleptic Agent To Treat Psychotic Disorders App 20090281078 - ROUTLEDGE; Carol ;   et al. | 2009-11-12 |
Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders App 20080306043 - Routledge; Carol ;   et al. | 2008-12-11 |
Combination of Sabcomeline with a Neuroleptic Agent to Treat Psychotic Disorders App 20080081804 - Routledge; Carol ;   et al. | 2008-04-03 |
Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive Disorders App 20070270428 - Hagan; James ;   et al. | 2007-11-22 |
Use of cyclooxygenase-2 selective inhibitors for the treatment of schizophrenic disorders App 20070142411 - Hagan; James ;   et al. | 2007-06-21 |
Use of 5HT-6 antagonists Grant 6,627,661 - Reavill , et al. September 30, 2 | 2003-09-30 |
Use of 5HT-6 antagonists App 20020094979 - Reavill, Charles Alan ;   et al. | 2002-07-18 |
Use of 5HT6 antagonists Grant 6,380,199 - Reavill , et al. April 30, 2 | 2002-04-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.